“…This peptide, when conjugated to a carrier molecule, has been shown to specifically inhibit the function of multiple immune cells including ' '"'Present address: Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland. 5Present address: Vacsyn S.A., Paris, France. lymphocytes (4,11,17,29,34), monocytes (13,14,18,35), and natural killer cells (15) in vitro. conjugates have also been shown to suppress cell-mediated immune responses in vivo (31).…”